# Ambrosia Biosciences Inc. — Form D

Ambrosia Biosciences Inc. of BOULDER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2024-08-07. The offering totals $25.0M, of which $12.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-08-07
- Form: D
- Accession: 0002032941-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $25.0M
- Amount sold: $12.5M
- Remaining: $12.5M
- Investors: 6
- Date of first sale: 2024-07-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-520756

## Issuer

- Name: Ambrosia Biosciences Inc.
- CIK: 0002032941
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 1941 PEARL STREET, BOULDER, CO, 80302
- Phone: (303) 351-5800

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| David S Snitman | Director | Boulder, CO |
| Nicholas Traggis | Director | Boulder, CO |
| Nicholas Traggis | Executive Officer | Boulder, CO |
| Kyle Lefkoff | Director | Boulder, CO |
| John S Orwin | Director | Boulder, CO |
| William S Marshall | Director | San Francisco, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-08-20](https://search.stillhousedata.com/formd/0001839365-24-000002) | D/A | $25.0M | $16.0M |

## More

- [CIK 2032941 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2032941&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002032941-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.